Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Edap TMSFRA:EDA -0.93%59 Return-on-Tangible-Asset is -51.54% as of Mar. 2026. GuruFocus rates FRA:EDA with a GF Score™ of 59/100 and a GF Value™ of €3.77 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 119 Medical Distribution companies, Edap TMS ranks worse than 97.48% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Edap TMS's annualizedNet Income for the quarter that ended in Mar. 2026 was €-31.43 Mil. Edap TMS's average total tangible assets for the quarter that ended in Mar. 2026 was €60.98 Mil. Therefore, Edap TMS's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -51.54%.
The historical rank and industry rank for Edap TMS's Return-on-Tangible-Asset or its related term are showing as below:
FRA:EDA'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -59.86 Med: -2.49 Max: 9.42
Current: -59.86
During the past 13 years, Edap TMS's highest Return-on-Tangible-Asset was 9.42%. The lowest was -59.86%. And the median was -2.49%.
FRA:EDA's Return-on-Tangible-Asset is ranked worse than 97.48% of 119
companies
in the Medical Distribution industry
Industry Median: 2.31
vs FRA:EDA: -59.86
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Edap TMS Return-on-Tangible-Asset Related Terms
Edap TMS Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Edap TMS's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:EDA vs ACH, YI, COSM: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Edap TMS's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edap TMS Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Edap TMS's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Edap TMS's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -51.54% mean?
Edap TMS (FRA:EDA) has a Return-on-Tangible-Asset of -51.54% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Edap TMS and its competitors. According to the industry distribution chart, Edap TMS ranks #116 out of 119 companies in the Medical Distribution industry, placing it in the top 97.5%.
Is Edap TMS's Return-on-Tangible-Asset too high?
Edap TMS's current Return-on-Tangible-Asset is -51.54%. Based on the distribution chart, Edap TMS ranks #116 out of 119 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Edap TMS has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Edap TMS's Return-on-Tangible-Asset compare to ACH and YI?
According to the Medical Distribution industry distribution chart, Edap TMS ranks #116 out of 119 companies for Return-on-Tangible-Asset. This places Edap TMS in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Edap TMS and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edap TMS's current Return-on-Tangible-Asset is -51.54%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edap TMS stock overvalued right now?
Based on GuruFocus' analysis, Edap TMS (FRA:EDA) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.77, compared to a current price of €5.30 — trading 40.6% above its estimated fair value. The current Return-on-Tangible-Asset is -51.54%. Edap TMS's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Edap TMS (FRA:EDA), the current Return-on-Tangible-Asset is -51.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edap TMS (FRA:EDA) Overvalued in 2026?
Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued.
The current stock price of €5.30 is trading 40.6% above its estimated GF Value™ of €3.77.
GuruFocus considers Edap TMS to be Significantly Overvalued.
Key valuation signals for FRA:EDA:
Return-on-Tangible-Asset: -51.54%
GF Value™: €3.77 vs. price of €5.30 (40.6% above fair value)
No single metric tells the full story. See the FRA:EDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
59GF Score
Get the complete analysis for FRA:EDA
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EDA has been successfully added to your 
